glp-1 news today october 9 2025 Out of Shortage, Into Controversy: The Fight Over Compounding GLP-1s Hold Promise as Treatment

10.1097/01.Jaa.0001007388.97793.41 20 CostesS.BertrandG.RavierM

The central nervous system actions of GLP-1 receptor agonists contribute substantially to their clinical benefits but also account for common tolerability issues

Tirzepatide is composed of 39 amino acids, is amidated at the C-terminal, conjugates a C20 fatty diacid moiety via a spacer connected to Lys 20 , and has a half-life of 116.7 h

Frequency of Administration: For significant deficiencies, initial injections may be given weekly, while others may only need monthly shots

Minneapolis Heart Institute Foundation: Johns Hopkins Medicine: The Pros, Cons, and Unknowns of Popular Weight Loss Drugs Obesity and Hypertension: Mechanisms, Risks, and Treatment